Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × iberdomide × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 9 Smoldering Multiple Myeloma 1 Recurrence 1 Neuroblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Ganglioneuroblastoma 1

Interventions

Cyclophosphamide 18 fludarabine 14 pembrolizumab 9 Etoposide 7 Dexamethasone 7 Rituximab 6 Gemcitabine 6 obinutuzumab 5 glofitamab 5 fludarabine phosphate 5 carfilzomib 4 Vincristine 4 Prednisone 4 Nivolumab 4 Carboplatin 4 zanubrutinib 3 ruxolitinib 3 pomalidomide 3 Paclitaxel 3 Lenalidomide 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Doxorubicin 3 venetoclax 2 tocilizumab 2 tisagenlecleucel 2 polatuzumab vedotin 2 ibrutinib 2 enzalutamide 2 duvelisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06215118 2026-03-27

MagnetisMM-30

Pfizer

Phase 1 Recruiting

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡